# Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)

Study · id `cardio:ct-nct07130175` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07130175](<https://clinicaltrials.gov/study/NCT07130175>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07130175

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.

## Technical summary

Registry record NCT07130175. Randomized; no masking; primary purpose treatment. Start 2022-12-31 (actual); primary completion 2024-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 118 participants (enrolled count; ClinicalTrials.gov record NCT07130175, source copy `cardio:ctgov-nct07130175-2025-08-19`, retrieved 2026-10-26)
- Started: 2022-12-31 (actual) (ClinicalTrials.gov record NCT07130175, source copy `cardio:ctgov-nct07130175-2025-08-19`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (actual) (ClinicalTrials.gov record NCT07130175, source copy `cardio:ctgov-nct07130175-2025-08-19`, retrieved 2026-10-26)
- Completion: 2024-12-31 (actual) (ClinicalTrials.gov record NCT07130175, source copy `cardio:ctgov-nct07130175-2025-08-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07130175, source copy `cardio:ctgov-nct07130175-2025-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07130175-2025-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)
- Condition: Polymorphic Ventricular Tachycardia
- Condition: Heart Failure
- Intervention (Device): Radiofrequency Catheter Ablation
- Intervention (Drug): Guideline-Directed Medical Therapy (GDMT)
- Lead sponsor: Qian Feng
- Lead sponsor class: OTHER
- Collaborator: The First Hospital of Zhangjiakou City
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 0c2294846ee7ed71efbb290e9360fe8f1bc5c2fb010ae00ed20dd4c82f32b823
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
